共 50 条
- [1] Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study[J]. ANNALS OF ONCOLOGY, 2021, 32 : S490 - S490Luo, T.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaZhang, Q.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaHe, P.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaZhong, X.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaYan, X.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaTian, T.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaHuang, J.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaZhang, Z.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R ChinaZheng, H.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Head Neck & Mammary Gland Oncol, Canc Ctr, Chengdu, Peoples R China
- [2] Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study[J]. CANCER MEDICINE, 2023, 12 (03): : 2333 - 2344Yin, Sha论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaChi, Yajing论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China Nankai Univ, Sch Med, Tianjin, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaDu, Yangyang论文数: 0 引用数: 0 h-index: 0机构: Linyi Canc Hosp, Dept Ward Breast Surg 2, Linyi, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaWang, Jingfen论文数: 0 引用数: 0 h-index: 0机构: Linyi Canc Hosp, Dept Ward Breast Surg 2, Linyi, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaShan, Changping论文数: 0 引用数: 0 h-index: 0机构: Jining Med Univ, Affiliated Hosp, Dept Breast & Thyroid Oncol, Jining, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaYi, Weiwei论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Shandong Prov Hosp, Dept Oncol, Jinan, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaShang, Mao论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Jinan Cent Hosp, Dept Oncol, Jinan, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaMan, Xiaochu论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaTan, Qiaorui论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R ChinaLi, Huihui论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Breast Med Oncol, Jinan 250017, Shandong, Peoples R China
- [3] Effectiveness and safety of pyrotinib-based therapy in patients with HER2-positive metastatic breast cancer: A real-world retrospective study[J]. CANCER MEDICINE, 2021, 10 (23): : 8352 - 8364Li, Chao论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaBian, Xiaoli论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China Heze Municipal Hosp, Dept Breast Surg, Heze, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaLiu, Zhaoyun论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaWang, Xinzhao论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaSong, Xiang论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaZhao, Wei论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaLiu, Yansong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R ChinaYu, Zhiyong论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Breast Canc Ctr, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China
- [4] Pyrotinib in the Treatment of Women With HER2-Positive Advanced Breast Cancer: A Multicenter, Prospective, Real-World Study[J]. FRONTIERS IN ONCOLOGY, 2021, 11Zhang, Lili论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R China Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaWu, Xiaohong论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Dept Oncol, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhou, Jun论文数: 0 引用数: 0 h-index: 0机构: First Peoples Hosp Lianyungang, Dept Thyroid & Breast Surg, Lianyungang, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhu, Mingzhen论文数: 0 引用数: 0 h-index: 0机构: Second Peoples Hosp Lianyungang, Dept Oncol, Lianyungang, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaYu, Hao论文数: 0 引用数: 0 h-index: 0机构: Zhenjiang First Peoples Hosp, Dept Oncol, Zhenjiang, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhang, Yusong论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Dept Oncol, Affiliated Hosp 2, Suzhou, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhao, Yutian论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Dept Radiotherapy & Oncol, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaHan, Zhengxiang论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Dept Oncol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaGuo, Yujiang论文数: 0 引用数: 0 h-index: 0机构: Wuxi Peoples Hosp, Dept Gen Surg, Wuxi, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaGuan, Xiaoqing论文数: 0 引用数: 0 h-index: 0机构: Suqian Peoples Hosp, Dept Breast Surg, Nanjing Drum Tower Hosp Grp, Suqian, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaWang, Xufen论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Peoples Hosp Changzhou 1, Dept Breast Surg, Affiliated Hosp 3, Changzhou, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaXu, Hong论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Dept Oncol, Affiliated Hosp 1, Suzhou, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaSun, Li论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Cent Hosp, Dept Oncol, Xuzhou, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhang, Jiaxin论文数: 0 引用数: 0 h-index: 0机构: Xuzhou Med Univ, Dept Thyroid & Breast Surg, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaZhuang, Min论文数: 0 引用数: 0 h-index: 0机构: First Peoples Hosp Lianyungang, Dept Oncol, Lianyungang, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaXie, Li论文数: 0 引用数: 0 h-index: 0机构: Nanjing Univ, Dept Oncol, Nanjing Drum Tower Hosp, Affiliated Hosp,Med Sch, Nanjing, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaYu, Shiyou论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Suzhou Municipal Hosp, Dept Thyroid & Breast Surg, Affiliated Suzhou Hosp, Suzhou, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaChen, Ping论文数: 0 引用数: 0 h-index: 0机构: Yancheng 1 Peoples Hosp, Dept Oncol, Yancheng, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R ChinaFeng, Jifeng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R China Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China Nanjing Med Univ, Dept Oncol, Jiangsu Canc Hosp, Nanjing, Peoples R China
- [5] The efficacy and safety of epirubicin and cyclophosphamide combined with pyrotinib in neoadjuvant treatment for HER2-positive breast cancer: A real-world study[J]. FRONTIERS IN ONCOLOGY, 2023, 13Li, Fu论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaLiang, Yimin论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaLuo, Ming论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaShen, Jiayue论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaZhou, Taosheng论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaLiang, Yajing论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R ChinaTang, Xiaoqi论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China论文数: 引用数: h-index:机构:Zeng, Jian论文数: 0 引用数: 0 h-index: 0机构: Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China Guangxi Med Univ, Dept Gastrointestinal & Gland Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China
- [6] Efficacy of lapatinib combined with capecitabine in patients with HER2-positive metastatic breast cancer in a real-world study[J]. ONCOLOGY LETTERS, 2020, 20 (06)Gui, Xinyu论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaLi, Huiping论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaYan, Ying论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaZhang, Ruyan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Breast Oncol, 52 Fucheng Rd, Beijing 100142, Peoples R China
- [7] Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer[J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7165 - 7174Sun, Ying论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Dept Pathol, Sch Basic Med Sci, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Qilu Hosp Qingdao, Dept Med Oncol, Qingdao 266035, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaChen, Beibei论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China Heze Municipal Hosp, Dept Radiat Oncol, Heze 274031, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaLi, Jisheng论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaPeng, Ling论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Prov Peoples Hosp, Dept Resp Dis, Hangzhou 310000, Zhejiang, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaLi, Shuguang论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaYu, Xuejun论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R ChinaLi, Li论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan 250012, Shandong, Peoples R China Shandong Univ, Cheeloo Coll Med, Key Lab Expt Teratol, Minist Educ, Jinan 250012, Shandong, Peoples R China
- [8] Real-world survival of Danish patients with HER2-positive metastatic breast cancer[J]. ACTA ONCOLOGICA, 2023, 62 (06) : 601 - 607Artzi, Daniel论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkBerg, Tobias论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkCelik, Alan论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkKumler, Iben论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Herlev Hosp, Dept Oncol, Herlev, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkKenholm, Julia论文数: 0 引用数: 0 h-index: 0机构: Godstrup Hosp, Dept Oncol, Godstrup, Herning, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkAl-Rawi, Sami论文数: 0 引用数: 0 h-index: 0机构: Naestved Hosp, Dept Oncol, Naestved, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkJensen, Maj-Britt论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkAndersson, Michael论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, DenmarkKnoop, Ann论文数: 0 引用数: 0 h-index: 0机构: Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Danish Breast Canc Grp, Copenhagen, Denmark Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
- [9] Real-world outcomes associated with pyrotinib-based therapy for HER2-positive metastatic breast cancer[J]. ANNALS OF ONCOLOGY, 2021, 32 : S489 - S489Hao, L.论文数: 0 引用数: 0 h-index: 0机构: USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R ChinaChen, J.论文数: 0 引用数: 0 h-index: 0机构: USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R ChinaChen, M.论文数: 0 引用数: 0 h-index: 0机构: USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R ChinaHan, X.论文数: 0 引用数: 0 h-index: 0机构: USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R ChinaPan, Y.论文数: 0 引用数: 0 h-index: 0机构: USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China USTC, Anhui Prov Hosp, Affiliated Hosp 1, Oncol, Hefei, Peoples R China
- [10] Pyrotinib in HER2-Positive local advanced or metastatic breast cancer patients: Results from a retrospective study in real-world setting[J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S58 - S58Wang, Q.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R ChinaChen, C.论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R ChinaWang, Y.论文数: 0 引用数: 0 h-index: 0机构: Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Wuhan, Xiangyang, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R ChinaSun, S.论文数: 0 引用数: 0 h-index: 0机构: Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R ChinaCheng, J.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Ctr Canc, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China